Cite
Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA.
MLA
Hanania, Nicola A., et al. “Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 10, no. 1, Jan. 2022, pp. 222–28. EBSCOhost, https://doi.org/10.1016/j.jaip.2021.08.006.
APA
Hanania, N. A., Fortis, S., Haselkorn, T., Gupta, S., Mumneh, N., Yoo, B., Holweg, C. T. J., & Chipps, B. E. (2022). Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA. The Journal of Allergy and Clinical Immunology. In Practice, 10(1), 222–228. https://doi.org/10.1016/j.jaip.2021.08.006
Chicago
Hanania, Nicola A, Spyridon Fortis, Tmirah Haselkorn, Sachin Gupta, Nayla Mumneh, Bongin Yoo, Cecile T J Holweg, and Bradley E Chipps. 2022. “Omalizumab in Asthma with Fixed Airway Obstruction: Post Hoc Analysis of EXTRA.” The Journal of Allergy and Clinical Immunology. In Practice 10 (1): 222–28. doi:10.1016/j.jaip.2021.08.006.